Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.41755
-0.0014 (-0.32%)
May 29, 2026, 1:23 PM EDT - Market open
Scienture Holdings Employees
As of December 31, 2025, Scienture Holdings had 9 total employees, including 4 full-time and 5 part-time employees. The number of employees decreased by 10 or -52.63% compared to the previous year.
Employees
9
Change (1Y)
-10
Growth (1Y)
-52.63%
Revenue / Employee
$53,075
Profits / Employee
-$4,650,059
Market Cap
16.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | -10 | -52.63% | 4 | 5 |
| Dec 31, 2024 | 19 | 0 | - | 14 | 5 |
| Jun 30, 2024 | 19 | - | - | 14 | 5 |
| Dec 31, 2023 | 19 | - | - | 14 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 390,000 |
| Johnson & Johnson | 138,200 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| OSR Holdings | 22 |
| BiomX | 20 |
| Cocrystal Pharma | 10 |
| Lexaria Bioscience | 7 |
SCNX News
- 11 days ago - SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion - GlobeNewsWire
- 22 days ago - Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline - GlobeNewsWire
- 22 days ago - Scienture announces third patent granted for Arbli - TheFly
- 23 days ago - SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 - GlobeNewsWire
- 6 weeks ago - Scienture granted 180-day extension to meet Nasdaq minimum bid price - TheFly
- 2 months ago - SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Why Is Scienture Holdings Stock (SCNX) Up Today? - TipRanks
- 2 months ago - Scienture formalized multiple GPO agreements for Rezenopy - TheFly